Deglycerolization of manually glycerolized, frozen red cell concentrates using a closed system cell processor
Transfusion · 2025
DOI: 10.1111/trf.18156 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Anita Howell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Innovation and Portfolio Management, Canadian Blood Services, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Glycerol, Erythrocytes, Cryopreservation, Blood Preservation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Blood Services.
Abstract (Originalsprache)
Background
Historically, red cell concentrates (RCCs) have been manually glycerolized and deglycerolized using an open system (COBE 2991, Terumo). Implementation of a closed system cell processor (ACP‐215, Haemonetics) for glycerolization and deglycerolization of RCCs creates a challenge for management of the historic cryopreserved RCC inventory. A study was undertaken to determine whether manually glycerolized frozen RCCs could be deglycerolized using the closed system processor, as the open system processors are being discontinued. Study Design and Methods Thirteen ABO/Rh matched RCCs were pooled and split to produce six large (approximately 354 mL) and six small (approximately 244 mL) RCCs. All units were stored for 14 days post‐collection, manually glycerolized and frozen at ≤ −65°C for ≥72 h. Half of the units of each size were deglycerolized using the COBE 2991 and resuspended in 0.9% saline, and the remaining units were centrifuged, deglycerolized on the ACP‐215, and resuspended AS‐3. RBC quality was tested at 24 ± 2 h post‐deglycerolization.
Results
All units deglycerolized on the ACP‐215 had significantly lower hemolysis ( p < .001) levels than those processed on the COBE2991. Large ACP‐215 deglycerolized units had lower hematocrits ( p < .05), hemoglobin ( p < .01), and recovery ( p = .001) than did large units deglycerolized on the COBE 2991. All ACP‐215 units met the regulatory standards for hemolysis, hematocrit, hemoglobin, and recovery.
Discussion
The closed‐system ACP‐215 processor significantly reduced post‐deglycerolization hemolysis in all units, and hemoglobin content in large units. The ACP‐215, in combination with a centrifugation step, is suitable for processing cryopreserved RCCs that have been manually glycerolized.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Innovation and Portfolio Management, Canadian Blood Services, Edmonton, Alberta, Canada.
- Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- Supply Chain Process Management, Canadian Blood Services, Edmonton, Alberta, Canada.
ORCID-Profile: Jason P Acker
Förderung
- Canadian Blood Services
Zitieren
APA
Howell, A., Kurach, J., William, N., Hill, A., Dennis, B., & Acker, J. P. (2025). Deglycerolization of manually glycerolized, frozen red cell concentrates using a closed system cell processor. Transfusion. https://doi.org/10.1111/trf.18156
Vancouver
Howell A, Kurach J, William N, Hill A, Dennis B, Acker JP. Deglycerolization of manually glycerolized, frozen red cell concentrates using a closed system cell processor. Transfusion. 2025. doi:10.1111/trf.18156
BibTeX
@article{Howell2025,
author = {Howell, Anita and Kurach, Jayme and William, Nishaka and Hill, Angela and Dennis, Brandie and Acker, Jason P},
title = {Deglycerolization of manually glycerolized, frozen red cell concentrates using a closed system cell processor},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18156}
}
EUVIMED